Partner Trial

Randomised, phase II/III, 3-stage trial to evaluate the safety and efficacy of the addition of olaparib to platinum-based neoadjuvant chemotherapy in breast cancer patients with triple negative and/or gBRCA sub-type.

Services

  • Ability to recontact
  • Access to the full pathology archive
  • Human functional tissue assays
  • Immunohistochemistry - scoring
  • Immunohistochemistry - staining
  • Tissue micro array creation
  • Nucleic acid extraction

Existing samples:

  • Malignant tumour of breast

Contact Information

Email:
Partner@addenbrookes.nhs.uk
Address:

Cambridge Cancer Trials Centre (S4), Box 279,
Addenbrookes Hospital,
Hills Road,
Cambridge
Cambridgeshire
CB2 0QQ
UK

Annual Statistics

Year Access Requests Received Access Requests Approved
Internal External Commercial Internal External Commercial
2015 N/A N/A N/A N/A N/A N/A
2016 N/A N/A N/A N/A N/A N/A
2017 N/A N/A N/A N/A N/A N/A
2018 N/A N/A N/A N/A N/A N/A
2019 N/A N/A N/A N/A N/A N/A